China

China

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.83 (6.95 - 8.75) 2019 Modelled IHME
7.9 (7.02 - 8.82) 2018 Modelled IHME
8.02 (7.11 - 8.94) 2017 Modelled IHME
8.23 (7.31 - 9.10) 2016 Modelled IHME
8.44 (7.53 - 9.34) 2015 Modelled IHME
8.57 (7.66 - 9.45) 2014 Modelled IHME
8.66 (7.76 - 9.57) 2013 Modelled IHME
8.75 (7.88 - 9.63) 2012 Modelled IHME
8.84 (7.97 - 9.75) 2011 Modelled IHME
8.95 (8.09 - 9.88) 2010 Modelled IHME
9.1 (8.22 - 10.03) 2009 Modelled IHME
9.28 (8.37 - 10.22) 2008 Modelled IHME
9.47 (8.54 - 10.44) 2007 Modelled IHME
9.69 (8.71 - 10.68) 2006 Modelled IHME
9.92 (8.91 - 10.94) 2005 Modelled IHME
10.24 (9.17 - 11.30) 2004 Modelled IHME
10.64 (9.46 - 11.80) 2003 Modelled IHME
11.04 (9.76 - 12.30) 2002 Modelled IHME
11.36 (10.01 - 12.69) 2001 Modelled IHME
11.51 (10.14 - 12.86) 2000 Modelled IHME
11.54 (10.23 - 12.83) 1999 Modelled IHME
11.56 (10.30 - 12.81) 1998 Modelled IHME
11.57 (10.34 - 12.77) 1997 Modelled IHME
11.58 (10.39 - 12.77) 1996 Modelled IHME
11.6 (10.41 - 12.76) 1995 Modelled IHME
11.63 (10.47 - 12.78) 1994 Modelled IHME
11.68 (10.50 - 12.82) 1993 Modelled IHME
11.75 (10.55 - 12.90) 1992 Modelled IHME
11.82 (10.58 - 13.01) 1991 Modelled IHME
11.91 (10.61 - 13.14) 1990 Modelled IHME
7.18 (5.85 - 8.69) 2015 Modelled WHO
6.1 (5.50 - 6.90) 2016 Modelled Razavi-Shearer et al, 2018
7.2 (6.70 - 7.70) 2006 Survey/reported Liang et al, 2009
6.89 (5.84 - 7.95) 2017 Modelled Wang et al, 2019
9.75 (4.49 - 17.85) 1992 Survey/reported Xia et al, 1996
5.49 (5.47 - 5.50) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.42 (0.34 - 0.51) 2019 Modelled IHME
0.43 (0.35 - 0.51) 2018 Modelled IHME
0.44 (0.35 - 0.52) 2017 Modelled IHME
0.44 (0.36 - 0.53) 2016 Modelled IHME
0.45 (0.37 - 0.54) 2015 Modelled IHME
0.47 (0.38 - 0.55) 2014 Modelled IHME
0.48 (0.39 - 0.57) 2013 Modelled IHME
0.5 (0.41 - 0.59) 2012 Modelled IHME
0.52 (0.43 - 0.61) 2011 Modelled IHME
0.55 (0.46 - 0.65) 2010 Modelled IHME
0.61 (0.50 - 0.71) 2009 Modelled IHME
0.71 (0.59 - 0.83) 2008 Modelled IHME
0.85 (0.71 - 1) 2007 Modelled IHME
1.05 (0.87 - 1.23) 2006 Modelled IHME
1.29 (1.07 - 1.51) 2005 Modelled IHME
2.21 (1.81 - 2.62) 2004 Modelled IHME
4 (3.26 - 4.81) 2003 Modelled IHME
6.08 (4.96 - 7.32) 2002 Modelled IHME
7.83 (6.40 - 9.43) 2001 Modelled IHME
8.65 (7.10 - 10.33) 2000 Modelled IHME
8.78 (7.26 - 10.44) 1999 Modelled IHME
8.88 (7.39 - 10.47) 1998 Modelled IHME
8.95 (7.47 - 10.47) 1997 Modelled IHME
9 (7.53 - 10.50) 1996 Modelled IHME
9.05 (7.57 - 10.56) 1995 Modelled IHME
9.09 (7.62 - 10.62) 1994 Modelled IHME
9.14 (7.65 - 10.65) 1993 Modelled IHME
9.18 (7.63 - 10.75) 1992 Modelled IHME
9.21 (7.65 - 10.81) 1991 Modelled IHME
9.23 (7.66 - 10.84) 1990 Modelled IHME
0.83 (0.56 - 1.18) 2015 Modelled WHO
0.3 (0.20 - 0.50) 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
140,931,000 (125,639,000 - 155,553,000) 1990 Modelled IHME
141,705,000 (126,807,000 - 155,894,000) 1991 Modelled IHME
142,440,000 (127,894,000 - 156,428,000) 1992 Modelled IHME
143,187,000 (128,742,000 - 157,151,000) 1993 Modelled IHME
144,001,000 (129,657,000 - 158,202,000) 1994 Modelled IHME
144,942,000 (130,144,000 - 159,541,000) 1995 Modelled IHME
146,002,000 (130,980,000 - 161,045,000) 1996 Modelled IHME
147,090,000 (131,556,000 - 162,354,000) 1997 Modelled IHME
148,131,000 (132,082,000 - 164,270,000) 1998 Modelled IHME
149,041,000 (132,075,000 - 165,698,000) 1999 Modelled IHME
149,725,000 (131,818,000 - 167,197,000) 2000 Modelled IHME
148,732,000 (130,952,000 - 166,078,000) 2001 Modelled IHME
145,394,000 (128,531,000 - 161,867,000) 2002 Modelled IHME
140,824,000 (125,139,000 - 156,144,000) 2003 Modelled IHME
136,165,000 (121,972,000 - 150,350,000) 2004 Modelled IHME
132,594,000 (118,983,000 - 146,110,000) 2005 Modelled IHME
130,047,000 (116,923,000 - 143,368,000) 2006 Modelled IHME
127,694,000 (115,063,000 - 140,647,000) 2007 Modelled IHME
125,572,000 (113,338,000 - 138,364,000) 2008 Modelled IHME
123,726,000 (111,777,000 - 136,307,000) 2009 Modelled IHME
122,193,000 (110,332,000 - 134,847,000) 2010 Modelled IHME
121,080,000 (109,105,000 - 133,499,000) 2011 Modelled IHME
120,342,000 (108,339,000 - 132,508,000) 2012 Modelled IHME
119,718,000 (107,291,000 - 132,197,000) 2013 Modelled IHME
118,907,000 (106,353,000 - 131,146,000) 2014 Modelled IHME
117,749,000 (105,061,000 - 130,212,000) 2015 Modelled IHME
115,462,000 (102,589,000 - 127,650,000) 2016 Modelled IHME
113,191,000 (100,311,000 - 126,084,000) 2017 Modelled IHME
111,980,000 (99,538,900 - 125,021,000) 2018 Modelled IHME
111,316,000 (98,865,200 - 124,425,000) 2019 Modelled IHME
86,007,000 (77,170,000 - 97,466,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.4 (9.33 - 13.70) 2019 Modelled IHME
11.2 (9.35 - 13.30) 2018 Modelled IHME
11.2 (9.43 - 13.10) 2017 Modelled IHME
11.1 (9.35 - 12.80) 2016 Modelled IHME
10.9 (9.45 - 12.50) 2015 Modelled IHME
10.8 (9.43 - 12.30) 2014 Modelled IHME
10.8 (9.44 - 12.40) 2013 Modelled IHME
11 (9.90 - 12.40) 2012 Modelled IHME
11.4 (10.10 - 12.70) 2011 Modelled IHME
11.7 (10.50 - 13.10) 2010 Modelled IHME
11.9 (10.70 - 13.10) 2009 Modelled IHME
12 (10.90 - 13.30) 2008 Modelled IHME
12 (10.90 - 13.10) 2007 Modelled IHME
12.2 (11 - 13.40) 2006 Modelled IHME
12.5 (11.30 - 13.90) 2005 Modelled IHME
13.1 (11.80 - 14.60) 2004 Modelled IHME
14.4 (13 - 15.90) 2003 Modelled IHME
16.2 (14.60 - 18.10) 2002 Modelled IHME
18.3 (16.40 - 20.30) 2001 Modelled IHME
19.9 (18 - 22.10) 2000 Modelled IHME
20.8 (18.90 - 23) 1999 Modelled IHME
21.1 (19 - 23.30) 1998 Modelled IHME
21.3 (19.30 - 23.40) 1997 Modelled IHME
21.4 (19.40 - 23.80) 1996 Modelled IHME
21.3 (19.10 - 23.80) 1995 Modelled IHME
21.1 (18.60 - 23.70) 1994 Modelled IHME
20.7 (18.10 - 23.70) 1993 Modelled IHME
20.3 (17.60 - 23.40) 1992 Modelled IHME
19.9 (17.10 - 23) 1991 Modelled IHME
19.3 (16.40 - 22.90) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
162,085 (132,642 - 195,155) 2019 Modelled IHME
159,172 (132,512 - 189,118) 2018 Modelled IHME
157,841 (133,101 - 184,965) 2017 Modelled IHME
155,068 (131,188 - 179,180) 2016 Modelled IHME
151,493 (131,791 - 174,152) 2015 Modelled IHME
149,695 (130,852 - 170,833) 2014 Modelled IHME
149,420 (130,514 - 170,751) 2013 Modelled IHME
151,898 (136,231 - 170,715) 2012 Modelled IHME
155,723 (138,467 - 173,474) 2011 Modelled IHME
159,449 (143,176 - 178,761) 2010 Modelled IHME
161,306 (146,022 - 178,400) 2009 Modelled IHME
163,065 (147,708 - 179,529) 2008 Modelled IHME
161,384 (146,709 - 177,145) 2007 Modelled IHME
163,252 (147,706 - 179,921) 2006 Modelled IHME
167,066 (151,330 - 185,654) 2005 Modelled IHME
174,747 (157,589 - 194,288) 2004 Modelled IHME
190,058 (171,905 - 210,087) 2003 Modelled IHME
212,669 (191,633 - 238,414) 2002 Modelled IHME
239,642 (214,259 - 266,254) 2001 Modelled IHME
259,334 (234,528 - 287,887) 2000 Modelled IHME
268,633 (244,493 - 296,526) 1999 Modelled IHME
270,075 (243,638 - 299,162) 1998 Modelled IHME
270,514 (246,081 - 298,211) 1997 Modelled IHME
270,305 (245,086 - 300,320) 1996 Modelled IHME
266,662 (238,286 - 298,078) 1995 Modelled IHME
260,890 (230,718 - 294,008) 1994 Modelled IHME
253,744 (221,973 - 290,245) 1993 Modelled IHME
245,998 (213,110 - 283,272) 1992 Modelled IHME
238,246 (204,895 - 275,324) 1991 Modelled IHME
228,718 (194,194 - 270,608) 1990 Modelled IHME
333,320 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
62 (58 - 67) 2019 Modelled IHME
63 (58 - 67) 2018 Modelled IHME
63 (59 - 67) 2017 Modelled IHME
63 (59 - 67) 2016 Modelled IHME
64 (60 - 67) 2015 Modelled IHME
64 (60 - 68) 2014 Modelled IHME
64 (61 - 68) 2013 Modelled IHME
65 (61 - 68) 2012 Modelled IHME
65 (62 - 68) 2011 Modelled IHME
65 (62 - 69) 2010 Modelled IHME
65 (62 - 69) 2009 Modelled IHME
65 (62 - 69) 2008 Modelled IHME
65 (62 - 69) 2007 Modelled IHME
65 (62 - 68) 2006 Modelled IHME
65 (62 - 69) 2005 Modelled IHME
66 (62 - 69) 2004 Modelled IHME
66 (63 - 69) 2003 Modelled IHME
66 (63 - 70) 2002 Modelled IHME
67 (63 - 70) 2001 Modelled IHME
67 (64 - 70) 2000 Modelled IHME
67 (64 - 70) 1999 Modelled IHME
67 (63 - 70) 1998 Modelled IHME
67 (63 - 70) 1997 Modelled IHME
67 (63 - 70) 1996 Modelled IHME
66 (63 - 70) 1995 Modelled IHME
66 (63 - 70) 1994 Modelled IHME
66 (63 - 70) 1993 Modelled IHME
66 (62 - 70) 1992 Modelled IHME
66 (62 - 70) 1991 Modelled IHME
66 (62 - 69) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
96 2018 Survey/reported WHO/UNICEF
96 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
94 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
91 2008 Survey/reported WHO/UNICEF
86 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
86 2005 Survey/reported WHO/UNICEF
76 2004 Survey/reported WHO/UNICEF
96 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
95 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
91 2006 Survey/reported WHO/UNICEF
84 2005 Survey/reported WHO/UNICEF
79 2004 Survey/reported WHO/UNICEF
75 2003 Survey/reported WHO/UNICEF
70 2002 Survey/reported WHO/UNICEF
65 2001 Survey/reported WHO/UNICEF
60 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
4 (3 - 6) 2015 Survey/reported National Health and Family Planning Commission of the People's Republic of China, 2015.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.34 (1.06 - 1.67) 2019 Modelled IHME
1.32 (1.05 - 1.65) 2018 Modelled IHME
1.28 (1.02 - 1.59) 2017 Modelled IHME
1.02 (0.81 - 1.27) 2016 Modelled IHME
0.79 (0.62 - 0.98) 2015 Modelled IHME
0.79 (0.63 - 0.99) 2014 Modelled IHME
0.81 (0.64 - 1) 2013 Modelled IHME
0.82 (0.65 - 1.02) 2012 Modelled IHME
0.83 (0.66 - 1.03) 2011 Modelled IHME
0.83 (0.66 - 1.04) 2010 Modelled IHME
0.83 (0.66 - 1.03) 2009 Modelled IHME
0.82 (0.64 - 1.02) 2008 Modelled IHME
0.8 (0.63 - 1) 2007 Modelled IHME
0.79 (0.62 - 0.98) 2006 Modelled IHME
0.79 (0.62 - 0.98) 2005 Modelled IHME
0.8 (0.63 - 1) 2004 Modelled IHME
0.84 (0.65 - 1.04) 2003 Modelled IHME
0.89 (0.69 - 1.11) 2002 Modelled IHME
0.95 (0.75 - 1.19) 2001 Modelled IHME
1.02 (0.80 - 1.28) 2000 Modelled IHME
1.11 (0.88 - 1.38) 1999 Modelled IHME
1.23 (0.99 - 1.52) 1998 Modelled IHME
1.37 (1.11 - 1.69) 1997 Modelled IHME
1.52 (1.23 - 1.85) 1996 Modelled IHME
1.64 (1.33 - 1.99) 1995 Modelled IHME
1.75 (1.42 - 2.13) 1994 Modelled IHME
1.85 (1.50 - 2.27) 1993 Modelled IHME
1.95 (1.57 - 2.40) 1992 Modelled IHME
2.05 (1.64 - 2.52) 1991 Modelled IHME
2.14 (1.71 - 2.65) 1990 Modelled IHME
0.7 (0.50 - 0.80) 2015 Modelled Blach et al, 2017
0.8 (0.20 - 1.20) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.91 (0.81 - 1.03) 2015 Modelled Gao et al, 2015
1.3 (0.40 - 2) 2014 Survey/reported Gower et al, 2014
3.2 (0.90 - 5.10) 1992 Survey/reported Xia et al, 1996
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
63.3 (52.20 - 73.20) 2019 Modelled Granados-Garcia V et al, 2019
43.1 (27.50 - 58.60) 2015 Modelled Degenhardt L et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
25,319,800 (20,268,300 - 31,323,800) 1990 Modelled IHME
24,553,900 (19,709,700 - 30,187,100) 1991 Modelled IHME
23,683,800 (19,087,700 - 29,096,100) 1992 Modelled IHME
22,713,800 (18,371,000 - 27,827,600) 1993 Modelled IHME
21,649,500 (17,528,400 - 26,381,500) 1994 Modelled IHME
20,496,800 (16,604,500 - 24,844,400) 1995 Modelled IHME
19,109,900 (15,498,300 - 23,289,000) 1996 Modelled IHME
17,477,400 (14,102,600 - 21,473,100) 1997 Modelled IHME
15,811,300 (12,655,300 - 19,535,800) 1998 Modelled IHME
14,329,200 (11,344,400 - 17,800,100) 1999 Modelled IHME
13,254,700 (10,396,200 - 16,627,300) 2000 Modelled IHME
12,453,300 (9,756,240 - 15,588,300) 2001 Modelled IHME
11,692,400 (9,147,830 - 14,630,900) 2002 Modelled IHME
11,055,800 (8,662,780 - 13,809,800) 2003 Modelled IHME
10,628,500 (8,361,490 - 13,254,000) 2004 Modelled IHME
10,497,400 (8,256,240 - 13,075,600) 2005 Modelled IHME
10,612,200 (8,334,820 - 13,189,300) 2006 Modelled IHME
10,822,400 (8,497,180 - 13,428,500) 2007 Modelled IHME
11,064,900 (8,725,660 - 13,764,300) 2008 Modelled IHME
11,275,800 (8,912,860 - 14,026,300) 2009 Modelled IHME
11,389,500 (9,008,000 - 14,204,700) 2010 Modelled IHME
11,369,900 (8,976,990 - 14,150,600) 2011 Modelled IHME
11,266,500 (8,896,540 - 13,999,200) 2012 Modelled IHME
11,135,200 (8,800,470 - 13,833,800) 2013 Modelled IHME
11,029,700 (8,744,950 - 13,705,400) 2014 Modelled IHME
11,018,300 (8,709,130 - 13,710,100) 2015 Modelled IHME
14,324,000 (11,380,100 - 17,859,300) 2016 Modelled IHME
18,034,800 (14,370,900 - 22,487,400) 2017 Modelled IHME
18,719,400 (14,895,200 - 23,365,600) 2018 Modelled IHME
19,020,400 (15,118,500 - 23,699,700) 2019 Modelled IHME
9,795,000 (6,675,000 - 10,832,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.49 (4.53 - 6.48) 2019 Modelled IHME
5.34 (4.52 - 6.31) 2018 Modelled IHME
5.27 (4.48 - 6.11) 2017 Modelled IHME
5.2 (4.42 - 6.07) 2016 Modelled IHME
5.12 (4.40 - 5.87) 2015 Modelled IHME
5 (4.35 - 5.75) 2014 Modelled IHME
4.81 (4.17 - 5.52) 2013 Modelled IHME
4.69 (4.14 - 5.33) 2012 Modelled IHME
4.66 (4.08 - 5.29) 2011 Modelled IHME
4.71 (4.13 - 5.29) 2010 Modelled IHME
4.8 (4.27 - 5.40) 2009 Modelled IHME
4.91 (4.35 - 5.54) 2008 Modelled IHME
4.94 (4.40 - 5.54) 2007 Modelled IHME
5.06 (4.52 - 5.67) 2006 Modelled IHME
5.19 (4.63 - 5.81) 2005 Modelled IHME
5.33 (4.74 - 5.95) 2004 Modelled IHME
5.55 (4.92 - 6.28) 2003 Modelled IHME
5.88 (5.23 - 6.59) 2002 Modelled IHME
6.28 (5.57 - 7.05) 2001 Modelled IHME
6.62 (5.88 - 7.37) 2000 Modelled IHME
6.79 (6.07 - 7.58) 1999 Modelled IHME
6.85 (6.12 - 7.64) 1998 Modelled IHME
6.92 (6.16 - 7.73) 1997 Modelled IHME
7 (6.20 - 7.88) 1996 Modelled IHME
7.01 (6.16 - 7.91) 1995 Modelled IHME
6.99 (6.15 - 7.90) 1994 Modelled IHME
6.97 (6.03 - 7.93) 1993 Modelled IHME
6.91 (5.95 - 7.88) 1992 Modelled IHME
6.86 (5.91 - 7.95) 1991 Modelled IHME
6.76 (5.76 - 7.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
78,041 (64,365 - 92,118) 2019 Modelled IHME
75,635 (64,114 - 89,393) 2018 Modelled IHME
74,406 (63,226 - 86,237) 2017 Modelled IHME
72,889 (62,055 - 85,146) 2016 Modelled IHME
71,379 (61,337 - 81,831) 2015 Modelled IHME
69,367 (60,405 - 79,760) 2014 Modelled IHME
66,526 (57,666 - 76,321) 2013 Modelled IHME
64,554 (56,885 - 73,386) 2012 Modelled IHME
63,780 (55,848 - 72,505) 2011 Modelled IHME
64,252 (56,400 - 72,216) 2010 Modelled IHME
65,264 (58,032 - 73,446) 2009 Modelled IHME
66,402 (58,944 - 74,925) 2008 Modelled IHME
66,536 (59,296 - 74,667) 2007 Modelled IHME
67,883 (60,591 - 76,095) 2006 Modelled IHME
69,278 (61,841 - 77,608) 2005 Modelled IHME
70,846 (63,052 - 79,101) 2004 Modelled IHME
73,451 (65,161 - 83,123) 2003 Modelled IHME
77,443 (68,789 - 86,792) 2002 Modelled IHME
82,132 (72,857 - 92,266) 2001 Modelled IHME
86,070 (76,439 - 95,900) 2000 Modelled IHME
87,732 (78,396 - 97,907) 1999 Modelled IHME
87,802 (78,425 - 97,987) 1998 Modelled IHME
88,006 (78,322 - 98,344) 1997 Modelled IHME
88,240 (78,229 - 99,382) 1996 Modelled IHME
87,569 (77,014 - 98,848) 1995 Modelled IHME
86,506 (76,209 - 97,842) 1994 Modelled IHME
85,383 (73,877 - 97,207) 1993 Modelled IHME
83,772 (72,119 - 95,547) 1992 Modelled IHME
82,230 (70,887 - 95,298) 1991 Modelled IHME
79,999 (68,189 - 92,764) 1990 Modelled IHME
10,188 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
18 (15 - 20) 2019 Modelled IHME
17 (15 - 20) 2018 Modelled IHME
17 (15 - 20) 2017 Modelled IHME
17 (15 - 19) 2016 Modelled IHME
17 (15 - 19) 2015 Modelled IHME
17 (15 - 19) 2014 Modelled IHME
17 (15 - 19) 2013 Modelled IHME
17 (15 - 19) 2012 Modelled IHME
17 (15 - 18) 2011 Modelled IHME
16 (15 - 18) 2010 Modelled IHME
17 (15 - 19) 2009 Modelled IHME
17 (15 - 19) 2008 Modelled IHME
17 (15 - 18) 2007 Modelled IHME
17 (15 - 19) 2006 Modelled IHME
17 (15 - 19) 2005 Modelled IHME
16 (15 - 18) 2004 Modelled IHME
16 (14 - 18) 2003 Modelled IHME
16 (14 - 18) 2002 Modelled IHME
16 (14 - 17) 2001 Modelled IHME
15 (14 - 17) 2000 Modelled IHME
16 (14 - 17) 1999 Modelled IHME
16 (14 - 17) 1998 Modelled IHME
16 (14 - 17) 1997 Modelled IHME
16 (14 - 18) 1996 Modelled IHME
16 (14 - 18) 1995 Modelled IHME
16 (14 - 18) 1994 Modelled IHME
16 (14 - 18) 1993 Modelled IHME
16 (14 - 18) 1992 Modelled IHME
16 (14 - 18) 1991 Modelled IHME
16 (14 - 18) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
4 (3 - 6) 2015 Survey/reported National Health and Family Planning Commission of the People's Republic of China, 2015.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2002
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
162,085
2019
(132,642 - 195,155)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
78,041
2019
(64,365 - 92,118)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
96 (%)
2019
WHO/UNICEF
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources